In addition, both genetic knockout of PRMT7 and its pharmacological inhibition by SGC3027 significantly suppressed NSCLC proliferation in vitro and tumorigenesis in vivo (Fig. 5a-i, and S3a-e). This evidence concerns the gene PRMT7 and non-small cell lung carcinoma.